Format

Send to

Choose Destination
Cancer Lett. 2017 Oct 28;407:9-20. doi: 10.1016/j.canlet.2017.08.011. Epub 2017 Aug 18.

MicroRNAs in prostate cancer: Functional role as biomarkers.

Author information

1
Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, 44106, USA.
2
Center of Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, 44115, USA; Department of Biological Sciences, Cleveland State University, Cleveland, OH, 44115, USA.
3
Department of Biochemistry, Purdue University, West Lafayette, IN, 47907, USA.
4
Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, 44106, USA; Department of Nutrition, Case Western Reserve University, Cleveland, OH, 44106, USA; Division of General Medical Sciences, Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA. Electronic address: sanjay.gupta@case.edu.

Abstract

MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene expression through post-transcriptional regulation of messenger RNA. Compelling evidence suggest the role of miRNA in cancer biology having potential as diagnostic, prognostic and predictive biomarkers. This review summarizes the current knowledge on miRNA deregulated in prostate cancer and their role as oncogene, tumor suppressor and metastasis regulators. The emerging information elucidating the biological function of miRNA is promising and may lead to their potential usefulness as diagnostic/prognostic markers and development as effective therapeutic tools for management of prostate cancer.

KEYWORDS:

Androgen receptor; Biomarkers; Castrate-resistant prostate cancer; Non-coding RNA; Oncomirs; Tumor suppressor

PMID:
28823964
DOI:
10.1016/j.canlet.2017.08.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center